"10.1371_journal.pone.0090353","plos one","2014-03-11T00:00:00Z","John C Morris; Antoinette R Tan; Thomas E Olencki; Geoffrey I Shapiro; Bruce J Dezube; Michael Reiss; Frank J Hsu; Jay A Berzofsky; Donald P Lawrence","Vaccine Branch and Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America; Department of Medicine, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America; Department of Medicine, The Ohio State University, Columbus, Ohio, United States of America; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America; Genzyme Corporation, Cambridge, Massachusetts, United States of America; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America","Conceived and designed the experiments: JCM FJH ART MR JAB. Performed the experiments: JCM ART TEO GIS BJD DPL. Analyzed the data: JCM FJH JAB. Contributed reagents/materials/analysis tools: JCM ART TEO GIS BJD DPL FJH JAB MR. Wrote the paper: JCM FJH JAB. Review, editing and approval of manuscript: JCM ART TEO GIS BJD DPL FJH JAB MR.","The authors have the following interests: FJ Hsu was an employee of Genzyme Corporation. JA Berzofsky received research support from Genzyme Corporation, and M Reiss was a consultant on Advisory Boards for Genzyme Corporation. This work was partly supported by Genzyme Corporation who also provided the investigational agent GC1008. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","03","John C Morris","JCM",9,TRUE,5,6,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
